"Designing Growth Strategies is in our DNA"

Antibiotic Infusion Therapy Market Size, Share & Industry Analysis, By Product (Drugs, Devices, and Services), By Antibiotics Class (Cephalosporins, Carbapenems, Glycopeptides, Aminoglycosides, Oxazolidinones & Lipopeptides, and Others), By Indication (Bloodstream Infections & Sepsis, Respiratory Tract Infections, Skin & Soft Tissue Infections, Urinary Tract & Intra-abdominal Infections, Bone & Joint Infections, and Others) By Age Group (Adults and Pediatric), By Setting (Hospitals, Outpatient Infusion Centers, Home Infusion, and Others), and Regional Forecast, 2026-2034

Last Updated: July 03, 2026 | Format: PDF | Report ID: FBI117934

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges 
    5. Market Trends
  4. Key Insights
    1. Epidemiology of Key Diseases, By Key Countries/Regions
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    3. New Product Launches, By Key Players
    4. Technological Advancements in Devices for Infusion Therapy
  5. Global Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Pfizer Inc.
      2. Fresenius Kabi AG
      3. Sandoz Inc.
      4. Baxter
      5. B. Braun SE
      6. BD
      7. ICU Medical, Inc.
      8. Terumo Corporation
      9. Option Care Health, Inc.
      10. KabaFusion
      11. Soleo Health
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges 
    5. Market Trends
  4. Key Insights
    1. Epidemiology of Key Diseases, By Key Countries/Regions
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    3. New Product Launches, By Key Players
    4. Technological Advancements in Devices for Infusion Therapy
  5. Global Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Antibiotic Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Services
    2. Market Analysis, Insights and Forecast – By Antibiotics Class
      1. Cephalosporins
      2. Carbapenems
      3. Glycopeptides
      4. Penicillins & Beta-lactam/Beta-lactamase Inhibitor Combinations
      5. Aminoglycosides
      6. Oxazolidinones & Lipopeptides
      7. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Bloodstream Infections & Sepsis
      2. Respiratory Tract Infections
      3. Skin & Soft Tissue Infections
      4. Urinary Tract & Intra-abdominal Infections
      5. Bone & Joint Infections 
      6. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Adults
      2. Pediatric 
    5. Market Analysis, Insights and Forecast – By Setting
      1. Hospitals
      2. Outpatient Infusion Centers
      3. Home Infusion
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Pfizer Inc.
      2. Fresenius Kabi AG
      3. Sandoz Inc.
      4. Baxter
      5. B. Braun SE
      6. BD
      7. ICU Medical, Inc.
      8. Terumo Corporation
      9. Option Care Health, Inc.
      10. KabaFusion
      11. Soleo Health
Read Less

Figure 1:  Global Antibiotic Infusion Therapy Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034

Figure 2:  Global Antibiotic Infusion Therapy Market Value Share (%), By Product, 2025 & 2034

Figure 3:  Global Antibiotic Infusion Therapy Market Value Share (%), By Antibiotics Class, 2025 & 2034

Figure 4:  Global Antibiotic Infusion Therapy Market Value Share (%), By Indication, 2025 & 2034

Figure 5:  Global Antibiotic Infusion Therapy Market Value Share (%), By Age Group, 2025 & 2034

Figure 6:  Global Antibiotic Infusion Therapy Market Value Share (%), By Setting, 2025 & 2034

Figure 7:  Global Antibiotic Infusion Therapy Market Value Share (%), By Region, 2025 & 2034

Figure 8:  North America Antibiotic Infusion Therapy Market Value (USD billion), By Product, 2025 & 2034

Figure 9:  North America Antibiotic Infusion Therapy Market Value Share (%), By Product, 2025

Figure 10:  North America Antibiotic Infusion Therapy Market Value (USD billion), By Antibiotics Class, 2025 & 2034

Figure 11:  North America Antibiotic Infusion Therapy Market Value Share (%), By Antibiotics Class, 2025

Figure 12:  North America Antibiotic Infusion Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 13:  North America Antibiotic Infusion Therapy Market Value Share (%), By Indication, 2025

Figure 14:  North America Antibiotic Infusion Therapy Market Value (USD billion), By Age Group, 2025 & 2034

Figure 15:  North America Antibiotic Infusion Therapy Market Value Share (%), By Age Group, 2025

Figure 16:  North America Antibiotic Infusion Therapy Market Value (USD billion), By Setting, 2025 & 2034

Figure 17:  North America Antibiotic Infusion Therapy Market Value Share (%), By Setting, 2025

Figure 18:  North America Antibiotic Infusion Therapy Market Value (USD billion), by Country, 2025 & 2034

Figure 19:  North America Antibiotic Infusion Therapy Market Value Share (%), by Country, 2025

Figure 20:  Europe Antibiotic Infusion Therapy Market Value (USD billion), By Product, 2025 & 2034

Figure 21:  Europe Antibiotic Infusion Therapy Market Value Share (%), By Product, 2025

Figure 22:  Europe Antibiotic Infusion Therapy Market Value (USD billion), By Antibiotics Class, 2025 & 2034

Figure 23:  Europe Antibiotic Infusion Therapy Market Value Share (%), By Antibiotics Class, 2025

Figure 24:  Europe Antibiotic Infusion Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 25:  Europe Antibiotic Infusion Therapy Market Value Share (%), By Indication, 2025

Figure 26:  Europe Antibiotic Infusion Therapy Market Value (USD billion), By Age Group, 2025 & 2034

Figure 27:  Europe Antibiotic Infusion Therapy Market Value Share (%), By Age Group, 2025

Figure 28:  Europe Antibiotic Infusion Therapy Market Value (USD billion), By Setting, 2025 & 2034

Figure 29:  Europe Antibiotic Infusion Therapy Market Value Share (%), By Setting, 2025

Figure 30:  Europe Antibiotic Infusion Therapy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 31:  Europe Antibiotic Infusion Therapy Market Value Share (%), by Country/ Sub-region, 2025

Figure 32:  Asia Pacific Antibiotic Infusion Therapy Market Value (USD billion), By Product, 2025 & 2034

Figure 33:  Asia Pacific Antibiotic Infusion Therapy Market Value Share (%), By Product, 2025

Figure 34:  Asia Pacific Antibiotic Infusion Therapy Market Value (USD billion), By Antibiotics Class, 2025 & 2034

Figure 35:  Asia Pacific Antibiotic Infusion Therapy Market Value Share (%), By Antibiotics Class, 2025

Figure 36:  Asia Pacific Antibiotic Infusion Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 37:  Asia Pacific Antibiotic Infusion Therapy Market Value Share (%), By Indication, 2025

Figure 38:  Asia Pacific Antibiotic Infusion Therapy Market Value (USD billion), By Age Group, 2025 & 2034

Figure 39:  Asia Pacific Antibiotic Infusion Therapy Market Value Share (%), By Age Group, 2025

Figure 40:  Asia Pacific Antibiotic Infusion Therapy Market Value (USD billion), By Setting, 2025 & 2034

Figure 41:  Asia Pacific Antibiotic Infusion Therapy Market Value Share (%), By Setting, 2025

Figure 42:  Asia Pacific Antibiotic Infusion Therapy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 43:  Asia Pacific Antibiotic Infusion Therapy Market Value Share (%), by Country/ Sub-region, 2025

Figure 44:  Latin America Antibiotic Infusion Therapy Market Value (USD billion), By Product, 2025 & 2034

Figure 45:  Latin America Antibiotic Infusion Therapy Market Value Share (%), By Product, 2025

Figure 46:  Latin America Antibiotic Infusion Therapy Market Value (USD billion), By Antibiotics Class, 2025 & 2034

Figure 47:  Latin America Antibiotic Infusion Therapy Market Value Share (%), By Antibiotics Class, 2025

Figure 48:  Latin America Antibiotic Infusion Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 49:  Latin America Antibiotic Infusion Therapy Market Value Share (%), By Indication, 2025

Figure 50:  Latin America Antibiotic Infusion Therapy Market Value (USD billion), By Age Group, 2025 & 2034

Figure 51:  Latin America Antibiotic Infusion Therapy Market Value Share (%), By Age Group, 2025

Figure 52:  Latin America Antibiotic Infusion Therapy Market Value (USD billion), By Setting, 2025 & 2034

Figure 53:  Latin America Antibiotic Infusion Therapy Market Value Share (%), By Setting, 2025

Figure 54:  Latin America Antibiotic Infusion Therapy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 55:  Latin America Antibiotic Infusion Therapy Market Value Share (%), by Country/ Sub-region, 2025

Figure 56:  Middle East & Africa Antibiotic Infusion Therapy Market Value (USD billion), By Product, 2025 & 2034

Figure 57:  Middle East & Africa Antibiotic Infusion Therapy Market Value Share (%), By Product, 2025

Figure 58:  Middle East & Africa Antibiotic Infusion Therapy Market Value (USD billion), By Antibiotics Class, 2025 & 2034

Figure 59:  Middle East & Africa Antibiotic Infusion Therapy Market Value Share (%), By Antibiotics Class, 2025

Figure 60:  Middle East & Africa Antibiotic Infusion Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 61:  Middle East & Africa Antibiotic Infusion Therapy Market Value Share (%), By Indication, 2025

Figure 62:  Middle East & Africa Antibiotic Infusion Therapy Market Value (USD billion), By Age Group, 2025 & 2034

Figure 63:  Middle East & Africa Antibiotic Infusion Therapy Market Value Share (%), By Age Group, 2025

Figure 64:  Middle East & Africa Antibiotic Infusion Therapy Market Value (USD billion), By Setting, 2025 & 2034

Figure 65:  Middle East & Africa Antibiotic Infusion Therapy Market Value Share (%), By Setting, 2025

Figure 66:  Middle East & Africa Antibiotic Infusion Therapy Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 67:  Middle East & Africa Antibiotic Infusion Therapy Market Value Share (%), by Country/ Sub-region, 2025

Figure 68:  Global Antibiotic Infusion Therapy Market Share (%), by Company, 2025

Table 1:  Global Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Product, 2021-2034 

Table 2:  Global Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Antibiotics Class, 2021-2034 

Table 3:  Global Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 4:  Global Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Age Group, 2021-2034

Table 5:  Global Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Setting, 2021-2034 

Table 6:  Global Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Region, 2021-2034 

Table 7:  North America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Product, 2021-2034 

Table 8:  North America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Antibiotics Class, 2021-2034 

Table 9:  North America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 10:  North America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Age Group, 2021-2034 

Table 11:  North America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Setting, 2021-2034 

Table 12:  North America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, by Country, 2021-2034 

Table 13:  Europe Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Product, 2021-2034 

Table 14:  Europe Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Antibiotics Class, 2021-2034 

Table 15:  Europe Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 16:  Europe Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Age Group, 2021-2034 

Table 17:  Europe Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Setting, 2021-2034 

Table 18:  Europe Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034 

Table 19:  Asia Pacific Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Product, 2021-2034 

Table 20:  Asia Pacific Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Antibiotics Class, 2021-2034 

Table 21:  Asia Pacific Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 22:  Asia Pacific Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Age Group, 2021-2034 

Table 23:  Asia Pacific Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Setting, 2021-2034 

Table 24:  Asia Pacific Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034 

Table 25:  Latin America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Product, 2021-2034

Table 26:  Latin America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Antibiotics Class, 2021-2034 

Table 27:  Latin America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 28:  Latin America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Age Group, 2021-2034 

Table 29:  Latin America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Setting, 2021-2034 

Table 30:  Latin America Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034 

Table 31:  Middle East & Africa Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Product, 2021-2034 

Table 32:  Middle East & Africa Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Antibiotics Class, 2021-2034 

Table 33:  Middle East & Africa Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 34:  Middle East & Africa Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Age Group, 2021-2034 

Table 35:  Middle East & Africa Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, By Setting, 2021-2034 

Table 36:  Middle East & Africa Antibiotic Infusion Therapy Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Antibiotic Infusion Therapy Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 198
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports